Foresite Capital Management III’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $5.75M | Hold |
|
|||||
|
2022
Q2 | $4.84M | Hold |
|
|||||
|
2022
Q1 | $5.11M | Hold |
|
|||||
|
2021
Q4 | $5.55M | Hold |
|
|||||
|
2021
Q3 | $5.99M | Hold |
|
|||||
|
2021
Q2 | $7.16M | Hold |
|
|||||
|
2021
Q1 | $7.45M | Hold |
|
|||||
|
2020
Q4 | $9.42M | Hold |
|
|||||
|
2020
Q3 | $11.9M | Buy |
|
|||||
|
2020
Q2 | $5.58M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $2.95M | Sell |
|
|||||
|
2019
Q3 | $7.72M | Sell |
|
|||||
|
2019
Q2 | $11.4M | Hold |
|
|||||
|
2019
Q1 | $21.1M | Hold |
|
|||||
|
2018
Q4 | $12.5M | Buy |
|
|||||
|
2018
Q3 | $17.3M | Hold |
|
|||||
|
2018
Q2 | $21M | Hold |
|
|||||
|
2018
Q1 | $20.3M | Buy |
|
|||||
|
2017
Q4 | $5.52M | Hold |
|
|||||
|
2017
Q3 | $4.84M | Buy |
|